Class information for:
Level 2: NEUROPEPTIDE Y//GLUCAGON LIKE PEPTIDE 1//GLP 1

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
461 15321 40.5 75%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 3)


ID, lev.
above		 Publications Label for level above
88 75755 ADRENOMEDULLIN//PEPTIDES//GALANIN

Classes in level below (level 1)


ID, lev. below Publications Label for level below
104 4263 GLUCAGON LIKE PEPTIDE 1//EXENATIDE//LIRAGLUTIDE
143 4075 NEUROPEPTIDE Y//Y 1 RECEPTOR//NPY
4292 1735 DPP 4 INHIBITOR//SITAGLIPTIN//VILDAGLIPTIN
5208 1588 ENDOCRINE CELLS//REGULATORY BIOSCI//REGULATORY PEPTIDE
12650 828 PEPTIDE YY//PYY//PYY3 36
12826 816 BRAIN SOMATOSTATIN//SOMATOSTATIN GENE REGULATION//MULTIELECTRODE SPIRAL CUFF
15878 618 GLUCAGON RECEPTOR//GLUCAGON RECEPTOR GENE//GLUCAGON ANTAGONIST
16497 585 PANCREATIC POLYPEPTIDE SECRETION//PANCREATOGENIC DIABETES//GIP RESPONSE
16632 579 CART PEPTIDE//COCAINE AND AMPHETAMINE REGULATED TRANSCRIPT//CART
25401 234 PANCREATIC DIABETES//INSULIN LIKE IMMUNOREACTIVITY//CALCIFYING PANCREATITIS

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of publ.
in class
1 NEUROPEPTIDE Y Author keyword 670 40% 9% 1327
2 GLUCAGON LIKE PEPTIDE 1 Author keyword 588 58% 4% 687
3 GLP 1 Author keyword 502 55% 4% 632
4 EXENATIDE Author keyword 387 73% 2% 296
5 LIRAGLUTIDE Author keyword 373 77% 2% 254
6 SITAGLIPTIN Author keyword 337 72% 2% 264
7 DPP 4 INHIBITOR Author keyword 334 85% 1% 174
8 INCRETIN Author keyword 314 66% 2% 288
9 VILDAGLIPTIN Author keyword 294 81% 1% 179
10 PEPTIDE YY Author keyword 209 56% 2% 258

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of publ.
in class		 LCSH search Wikipedia search
1 NEUROPEPTIDE Y 670 40% 9% 1327 Search NEUROPEPTIDE+Y Search NEUROPEPTIDE+Y
2 GLUCAGON LIKE PEPTIDE 1 588 58% 4% 687 Search GLUCAGON+LIKE+PEPTIDE+1 Search GLUCAGON+LIKE+PEPTIDE+1
3 GLP 1 502 55% 4% 632 Search GLP+1 Search GLP+1
4 EXENATIDE 387 73% 2% 296 Search EXENATIDE Search EXENATIDE
5 LIRAGLUTIDE 373 77% 2% 254 Search LIRAGLUTIDE Search LIRAGLUTIDE
6 SITAGLIPTIN 337 72% 2% 264 Search SITAGLIPTIN Search SITAGLIPTIN
7 DPP 4 INHIBITOR 334 85% 1% 174 Search DPP+4+INHIBITOR Search DPP+4+INHIBITOR
8 INCRETIN 314 66% 2% 288 Search INCRETIN Search INCRETIN
9 VILDAGLIPTIN 294 81% 1% 179 Search VILDAGLIPTIN Search VILDAGLIPTIN
10 PEPTIDE YY 209 56% 2% 258 Search PEPTIDE+YY Search PEPTIDE+YY

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of publ.
in class
1 GLUCAGON LIKE PEPTIDE 1 1479 45% 16% 2446
2 PEPTIDE YY 778 61% 5% 837
3 7 36 AMIDE 754 90% 2% 329
4 GASTRIC INHIBITORY POLYPEPTIDE 719 61% 5% 759
5 NPY 693 71% 4% 559
6 DIPEPTIDYL PEPTIDASE 4 INHIBITOR 687 77% 3% 462
7 PANCREATIC POLYPEPTIDE 660 59% 5% 743
8 DEPENDENT INSULINOTROPIC POLYPEPTIDE 516 72% 3% 403
9 GLP 1 444 58% 3% 515
10 EXENDIN 4 405 70% 2% 332

Journals


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 DIABETES OBESITY & METABOLISM 58 17% 2% 322
2 JOURNAL OF DIABETES INVESTIGATION 8 14% 0% 58
3 FRONTIERS OF HORMONE RESEARCH 4 17% 0% 22

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes 2006 1261 81 89%
Biology of incretins: GLP-1 and GIP 2007 1012 229 85%
The physiology of glucagon-like peptide 1 2007 771 305 87%
The biology of incretin hormones 2006 858 126 87%
Pharmacology, Physiology, and Mechanisms of Incretin Hormone Action 2013 123 142 76%
Cardiovascular Biology of the Incretin System 2012 160 216 79%
A review of gliptins for 2014 2015 4 149 91%
Efficacy and safety of incretin therapy in type 2 diabetes - Systematic review and meta-analysis 2007 492 39 79%
GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus 2012 105 114 96%
Incretin-based therapies for type 2 diabetes mellitus 2009 258 43 98%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 SAAD PHARM DIABET 37 54% 0.3% 47
2 BANTING BEST DIABET 32 31% 0.6% 85
3 THER EUT AREA METAB 31 92% 0.1% 12
4 NNF BASIC METAB 21 47% 0.2% 33
5 INTERNAL MED F 19 29% 0.4% 57
6 LILLY DIABET 15 68% 0.1% 13
7 GASTROINTESTINAL HORMONES 15 88% 0.0% 7
8 REGULATORY PEPTIDE 14 42% 0.2% 27
9 DIABET CLIN NUTR ENDOCRINOL 14 64% 0.1% 14
10 DIABET METAB TRANSLAT MED UNIT 10 61% 0.1% 11

Related classes at same level (level 2)


Rank Relatedness score Related classes
1 0.0000015869 GPR40//GPR119//GPR120
2 0.0000015738 GALANIN//GALANIN RECEPTORS//GALANIN RECEPTOR
3 0.0000011800 GHRELIN//OBESTATIN//NESFATIN 1
4 0.0000011063 PACAP//PITUITARY ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE//VIP
5 0.0000009671 ISLET TRANSPLANTATION//PANCREATIC ISLETS//ISLET
6 0.0000009506 PHYSIOLOGY & BEHAVIOR//FOOD INTAKE//CONDITIONED TASTE AVERSION
7 0.0000008720 CHOLECYSTOKININ//L 365 260//GASTRIN
8 0.0000008389 CD26//PROLYL OLIGOPEPTIDASE//PROLIDASE
9 0.0000007695 MELANOCORTIN//MELANOCORTIN RECEPTOR//MELANOCORTIN RECEPTORS
10 0.0000007490 NEUROTENSIN//SR 48692//NEUROTENSIN RECEPTOR